“Biomarker-Guided Drug Repurposing and Molecular Validation of Angiotensin-2 Receptor Type-1 in Brain Tumor”, Precis. Med. Com., vol. 3, no. 1, pp. 27–42, Jun. 2023, doi: 10.55627/pmc.003.01.0296.